Annual Interest Expense in USD from 2010 to 2023

Taxonomy & unit: us-gaap: USD
Description: Amount of the cost of borrowed funds accounted for as interest expense.
Summary: Elite Pharmaceuticals Inc /Nv/ quarterly/annual Interest Expense history and growth rate from 2010 to 2023.
Elite Pharmaceuticals Inc /Nv/ Interest Expense for the quarter ending March 31, 2024 was $217K, a 34.3% decline year-over-year.
Elite Pharmaceuticals Inc /Nv/ Interest Expense for the twelve months ending March 31, 2024 was $589K, a 47.1% decline year-over-year.
Elite Pharmaceuticals Inc /Nv/ annual Interest Expense for 2023 was $589K, a 47.1% decline from 2022.
Elite Pharmaceuticals Inc /Nv/ annual Interest Expense for 2022 was $1.11M, a 480% increase from 2021.
Elite Pharmaceuticals Inc /Nv/ annual Interest Expense for 2021 was $192K, a 26.1% decline from 2020.

Interest Expense, Trailing 12 Months (USD)

Interest Expense, Annual (USD)

Interest Expense, YoY Annual Growth (%)

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
2023	$589K	-$524K	-47.1%	Apr 1, 2023	Mar 31, 2024	10-K	2024-07-01
2022	$1.11M	+$921K	+480%	Apr 1, 2022	Mar 31, 2023	10-K	2024-07-01
2021	$192K	-$67.8K	-26.1%	Apr 1, 2021	Mar 31, 2022	10-K	2023-06-29
2020	$260K	-$96.3K	-27.1%	Apr 1, 2020	Mar 31, 2021	10-K	2022-06-29
2019	$356K	-$13.3K	-3.6%	Apr 1, 2019	Mar 31, 2020	10-K	2021-06-14
2018	$369K	+$33.7K	+10%	Apr 1, 2018	Mar 31, 2019	10-K	2020-06-30
2017	$335K	+$97.3K	+40.8%	Apr 1, 2017	Mar 31, 2018	10-K	2019-06-21
2016	$238K	-$42.4K	-15.1%	Apr 1, 2016	Mar 31, 2017	10-K	2018-06-14
2015	$281K	-$6.56K	-2.28%	Apr 1, 2015	Mar 31, 2016	10-K	2018-06-14
2014	$287K	-$572K	-66.6%	Apr 1, 2014	Mar 31, 2015	10-K	2017-06-14
2013	$859K	+$606K	+239%	Apr 1, 2013	Mar 31, 2014	10-K	2016-06-15
2012	$254K	+$24.2K	+10.5%	Apr 1, 2012	Mar 31, 2013	10-K	2014-06-30
2011	$230K	-$2.15K	-0.93%	Apr 1, 2011	Mar 31, 2012	10-K	2013-06-21
2010	$232K			Apr 1, 2010	Mar 31, 2011	10-K	2012-06-29

* An asterisk sign (*) next to the value indicates that the value is likely invalid.